A. Alsuliman

发表

Membrane bioreactor treating kraft evaporative condensate at a high temperature under different operational conditions and turpentine shockloads

A. Alsuliman, 2003 .

Specific combinations of donor and recipient KIR-HLA genotypes predict for large differences in outcome after cord blood transplantation.

R. Başar, K. Rezvani, D. Marin, 2016, Blood.

Leukemia-induced phenotypic and functional defects in natural killer cells predict failure to achieve remission in acute myeloid leukemia

K. Rezvani, D. Marin, E. Shpall, 2014, Haematologica.

KIR2DS1 genotype predicts for complete cytogenetic response and survival in newly diagnosed chronic myeloid leukemia patients treated with imatinib

D. Marin, L. Foroni, D. Milojković, 2012, Leukemia.

Interaction between KIR3DS1 and HLA-Bw4 predicts for progression-free survival after autologous stem cell transplantation in patients with multiple myeloma.

K. Rezvani, D. Marin, L. Foroni, 2010, Blood.

Large-scale GMP-compliant CRISPR-Cas9-mediated deletion of the glucocorticoid receptor in multivirus-specific T cells.

Matthew S. McNeill, M. McNeill, R. Başar, 2020, Blood advances.

A subset of virus-specific CD161+ T cells selectively express the multidrug transporter MDR1 and are resistant to chemotherapy in AML.

R. Başar, K. Rezvani, D. Marin, 2017, Blood.

Ibrutinib modulates the immunosuppressive CLL microenvironment through STAT3-mediated suppression of regulatory B-cell function and inhibition of the PD-1/PD-L1 pathway

Z. Estrov, D. Harris, R. Başar, 2018, Leukemia.

Humoral and cellular immunity to primary H1N1 infection in patients with hematologic malignancies following stem cell transplantation.

S. Brett, K. Rezvani, D. Marin, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A robust, good manufacturing practice-compliant, clinical-scale procedure to generate regulatory T cells from patients with amyotrophic lateral sclerosis for adoptive cell therapy.

R. Başar, K. Rezvani, E. Shpall, 2016, Cytotherapy.

ALS patients' regulatory T lymphocytes are dysfunctional, and correlate with disease progression rate and severity.

E. Shpall, S. Appel, D. Beers, 2017, JCI insight.

IL-10+ regulatory B cells are enriched in cord blood and may protect against cGVHD after cord blood transplantation.

R. Başar, K. Rezvani, D. Marin, 2016, Blood.

Evidence for B Cell Exhaustion in Chronic Graft-versus-Host Disease

R. Başar, K. Rezvani, D. Marin, 2018, Front. Immunol..

The CXCR4–STAT3–IL-10 Pathway Controls the Immunoregulatory Function of Chronic Lymphocytic Leukemia and Is Modulated by Lenalidomide

Z. Estrov, D. Harris, R. Başar, 2018, Front. Immunol..

Towards targeting PD-1/PD-L1 axis in breast cancer, pre-clinical data

D. Çolak, A. Tulbah, A. Alsuliman, 2015, Journal of Immunotherapy for Cancer.

Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD.

K. Rezvani, S. Parmar, E. Shpall, 2014, Blood.

Tyrosine kinase inhibitors impair B-cell immune responses in CML through off-target inhibition of kinases important for cell signaling.

K. Rezvani, D. Marin, E. Shpall, 2013, Blood.

Targeting the αv integrin-TGF-β axis improves natural killer cell function against glioblastoma stem cells.

Fang Wang, Dihua Yu, R. Başar, 2021, The Journal of clinical investigation.

Bidirectional crosstalk between PD-L1 expression and epithelial to mesenchymal transition: Significance in claudin-low breast cancer cells

Olfat Al-Harazi, D. Çolak, T. Al-Tweigeri, 2015, Molecular Cancer.

Bidirectional crosstalk between PD-L1 expression and epithelial to mesenchymal transition: Significance in claudin-low breast cancer cells

Olfat Al-Harazi, D. Çolak, T. Al-Tweigeri, 2015, Molecular Cancer.

Dasatinib may overcome the negative prognostic impact of KIR2DS1 in newly diagnosed patients with chronic myeloid leukemia.

K. Rezvani, R. Clark, D. Marin, 2012, Blood.

Inhibition of the αv integrin-TGF-β axis improves natural killer cell function against glioblastoma stem cells

Dihua Yu, R. Başar, K. Rezvani, 2020, bioRxiv.

Glioblastoma-mediated Immune Dysfunction Limits CMV-specific T Cells and Therapeutic Responses: Results from a Phase I/II Trial

G. Fuller, J. Huse, G. Rao, 2020, Clinical Cancer Research.

Ibrutinib Can Modulate the T Cell Response in Chronic Lymphocytic Leukemia By Reducing PD1/PDL1 Interactions

K. Rezvani, E. Shpall, J. Burger, 2015 .

A subset of virus-specific CD161+ T cells selectively express the multidrug transporter MDR1 and are resistant to chemotherapy in AML.

R. Başar, K. Rezvani, D. Marin, 2017, Blood.